Individuals who received joint calcium-vitamin D supplements tended to have a decrease in serum high-sensitivity C-reactive protein levels compared with placebo after controlling for baseline levels ( -1.14 0.25 vs 0.02 0.24 ng/mL , P = .09 ) .